Titres of specific antibodies to poliovirus type 3 and tetanus toxoid in saliva and serum of children with recurrent upper respiratory tract infections

Pediatric Allergy and Immunology

Volumn 12, Issue 1, 2001, Pages 42-48

  Cardinale, Fabio ^a,b   Gentile, Vita ^a   Brunetti, Luigia ^a   Hanson, Lars Åke ^b   Armenio, Lucio ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

IgG; Pediatric; Recurrent upper respiratory tract infections; Secretory IgA; Vaccine antigens

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; ORAL POLIOMYELITIS VACCINE; TETANUS TOXOID;

ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; POLIOVIRUS; RECURRENCE; RESPIRATORY TRACT INFECTIONS; SALIVA; TETANUS TOXOID;

EID: 0035119126     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3038.2001.012001042.x     Document Type: Article

References (31)

1. The clinical impact of human respiratory virus infections
2. Childhood upper respiratory tract infections: To what degree is incidence affected by day-care attendance?
3. Subclinical trace element deficiency in children with undue susceptibility to infections
4. Spectrum of IgG2 subclass deficiency in children with recurrent infections: Prospective study
5. Cell-mediated immune status of children with recurrent infection
6. Neutrophil function in infection-prone children
7. The role of humoral mucosal immunity in the induction and maintenance of chronic airway infections
8. The mucosal immune system: From fundamental concepts to vaccine development
9. Saliva as a manifestation of the common mucosal system
10. Serum IgG subclass concentrations in healthy subjects at different age: Age normal percentile charts
11. Human secretory immunoglobulins. I. Salivary secretions from individuals with normal or low levels of serum immunoglobulins
12. Application of the ELISA for determination of immunoglobulin class-specific Escherichia coli antibodies
13. Aberrations in titre and avidity of serum IgM and IgG antibodies to microbial and food antigens in IgA deficiency
14. Antibody avidity determination by ELISA using thiocyanate elution
15. Low-level air pollution and upper respiratory infections in children
16. Human secretory immunoglobulin M. An immunochemical and immunohistochemical study
17. Selection of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A
18. Peyer's patches: An enriched source of precursors for IgA-producing immunocytes in the rabbit
19. Mucosal immunology of the upper respiratory tract
20. Is BALT a major component of the human lung immune system?
21. Salivary IgA levels in atopic children
22. Reduced concentration of secretory IgA indicates changes of local immunity in children with adenoid hyperplasia and secretory otitis media
23. Salivary anti-RSV IgA antibodies and respiratory infections during the first year of life in atopic and non-atopic infants
24. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides
25. Immunoglobulin A1 and A2 subclass of salivary antibodies to Candida albicans in patients with oral candidosis
26. Salivary immunoglobulins
27. Cells producing immunoglobulins and other immune factors in human nasal mucosa
28. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections
29. Selective deficiency in pneumococcal antibody response in children with recurrent infections
30. A prospective, double-blind, placebo-controlled trial of i.v. immunoglobulin and trimethoprim-sulfamethoxazole in children with recurrent respiratory tract infections